2005
DOI: 10.1016/j.ijpharm.2005.04.029
|View full text |Cite
|
Sign up to set email alerts
|

Encapsulation efficiency of water-soluble and insoluble drugs in liposomes prepared by the microencapsulation vesicle method

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
150
0

Year Published

2007
2007
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 276 publications
(156 citation statements)
references
References 16 publications
6
150
0
Order By: Relevance
“…However, co-encapsulation rates of both 5-FU and its modulator were relatively poor (11 and 26%, respectively). Such a moderate encapsulation rate for 5-FU is not surprising when considering the polar and amphoterous properties of this drug, that render its handling quite difficult when preparing standard pegylated liposomes, as used here (Nii and Ishii, 2005). Indeed, our strategy was to develop a stealth delivery system as basic and as simple as possible, to easily standardise a fabrication process that could be performed in most laboratories equipped with standard apparatus and reagents.…”
Section: Discussionmentioning
confidence: 98%
See 1 more Smart Citation
“…However, co-encapsulation rates of both 5-FU and its modulator were relatively poor (11 and 26%, respectively). Such a moderate encapsulation rate for 5-FU is not surprising when considering the polar and amphoterous properties of this drug, that render its handling quite difficult when preparing standard pegylated liposomes, as used here (Nii and Ishii, 2005). Indeed, our strategy was to develop a stealth delivery system as basic and as simple as possible, to easily standardise a fabrication process that could be performed in most laboratories equipped with standard apparatus and reagents.…”
Section: Discussionmentioning
confidence: 98%
“…Beside these higher plasma levels, sustained exposure to the drug was achieved, as liposomal d-Ino remained fully detectable 2 h after administration, whereas free d-Ino was totally cleared. Despite its extremely widespread use in clinical oncology, few reports have focused on encapsulating 5-FU in simple carriers, probably as a result of its polar and amphotereous properties that render it particularly difficult to entrap in standard liposomes (Simmons and Krame, 1977;Nii and Ishii, 2005). However, as a prodrug, 5-FU presents an opportunity to increase its therapeutic efficacy by combining it with biochemical modulators that can improve its intratumoural activation pattern.…”
Section: Discussionmentioning
confidence: 99%
“…Centrifugation method was used to separate free molecules from the micelles based on their different ability to cross through the membrane with different sizes of pores upon centrifugation [13]. We first evaluated the recovery of free CPT-11 solution in the procedure.…”
Section: The Centrifugation Methodsmentioning
confidence: 99%
“…For the latter application, one typically employs liposomes encapsulating a sufficient amount of therapeutic agents. These liposomes have the ability to carry the substance in aqueous fluids (bloodstream) and modulate the drug biodistribution 12. The light exposure of liposomes, made of photoswitchable lipids can indeed trigger a rapid release of the vesicle content 13…”
Section: Introductionmentioning
confidence: 99%